Product Description
5MG
Tirzeis a synthetically modified analog of gastric inhibitory polypeptide with affinity at the glucagon-like peptide-1 (GLP-1) receptor.
It was recently approved in the US to help type 2 diabetes patients better manage blood sugar. Tirzeis under active study as a weight loss agent.
Tirze is a compound that has been shown to help with weight loss by reducing food intake and increasing feelings of fullness. It works by targeting the gut hormones that regulate appetite and metabolism. Tirze is a GLP-1 receptor agonist, which means that it activates the GLP-1 receptors in the gut and stimulates the release of hormones that signal the brain to reduce food intake and increase feelings of fullness. Research trials have shown that Tirzepatide can lead to significant weight loss in animal models when used in combination with a calorie-controlled diet and increased physical activity.
The products offered on this website are NOT INTENDED TO DIAGNOSE, CURE, MITIGATE, TREAT or PREVENT DISEASE.
Licensed researchers may also buy tirzeas a reference material for laboratory experimentation only.
